Global Citric Acid Market Size, Share & Forecast, By Form, Grade, Application & End-Use Industry, 2026-2031

The Global Citric Acid Market was valued at USD 4,040 million in 2025. The estimate covers merchant sales of anhydrous, monohydrate and liquid citric acid across food, pharmaceutical, cleaning, personal care and industrial applications. Food and beverages remain the largest demand pool, while Asia Pacific is the leading regional market and production base. The market's scale reflects recurring formulation requirements rather than discretionary use, which supports relatively stable demand through economic cycles. Trade concentration, however, means realized prices and regional margins can diverge materially because freight, duties, feedstock costs and grade qualification affect landed economics.

The market is forecast to reach USD 5,445 million by 2031, expanding at a 5.10% CAGR from 2026 to 2031. Growth is expected to remain steady because citric acid performs essential functions in food preservation, beverage acidulation, pharmaceutical buffering, chelation and cleaning. Volume is projected to increase to 3,960 thousand tons, while average selling value moves toward USD 1,375 per ton as high-purity, liquid and documented grades improve the product mix. The forecast assumes continued processed-food expansion, moderate price improvement, incremental Asian capacity and no prolonged disruption to fermentation feedstocks or international trade flows.

Profit pools are expected to shift toward pharmaceutical grade, high-purity food grade, liquid delivery systems and application-specific citrate solutions. These segments require stronger documentation, purification, analytical testing, packaging and customer qualification, allowing suppliers to defend premiums beyond bulk commodity pricing. Cleaning and chelation applications also provide attractive growth because buyers value cost-in-use, biodegradability and performance rather than price per ton alone. By contrast, standard food-grade crystalline material will remain the largest volume pool but face greater price pressure from Asian capacity and transparent international trade. Distribution services, regional inventory and origin diversification will also capture incremental margin.

The most important structural risk is the concentration of global supply and export availability in China and nearby Asian production centers. China exported 1.246 million tons of citric acid in 2024, creating significant influence over international benchmark pricing and supply continuity. This concentration interacts with trade remedies, including EU producer-specific anti-dumping duties, and can produce large differences in landed cost across buyers. Producers outside Asia face higher energy and compliance costs, while buyers face origin, logistics and qualification risks. A major capacity outage, tariff revision or freight disruption could therefore affect availability and pricing across multiple downstream industries simultaneously.

Asia Pacific is the largest regional market at USD 1,414 million in 2025 and is expected to grow at 5.40% through 2031. North America and Europe are mature, high-value consumption regions with strong food, beverage, pharmaceutical and cleaning demand, but forecast growth is lower at 4.40% and 4.20%, respectively. Latin America is projected to grow at 5.60%, supported by processed-food and beverage demand, while Middle East and Africa leads regional growth at 6.30% from a smaller base. Regional attractiveness therefore depends on whether an investor prioritizes scale, growth, import substitution or premium-grade consumption.

Food and beverage applications will contribute the largest absolute increase because they account for nearly half of current demand and require citric acid for pH control, preservation, flavor balance and processing stability. However, cleaning, chelation and high-purity pharmaceutical uses should contribute a disproportionate share of incremental margin. Detergent and household-cleaner demand is forecast to grow faster than the overall market as formulators pursue phosphate-reduced and lower-concern systems. Pharmaceutical and nutraceutical demand benefits from effervescent dosage growth, buffering needs and quality documentation. The combined effect creates a stable volume core with faster-growing specialty layers.